Loreta Kondili MD, Ph.D. is a Clinical Researcher at the Center for Global Health of the Italian
Institute of Health (Istituto Superiore di Sanità) in Rome. Dr. Kondili has worked in viral hepatitis
and liver diseases for the last 25 years, and her main research focuses on epidemiology, clinical
profiles, and therapy of chronic viral liver disease. She has been involved in the scientific
coordination of several Italian networks in the field of chronic liver disease. She established and is
currently leading the Italian Platform for the Study of Viral hepatitis (HCV, HBV, and HDV)
Therapies (PITER) through more than 100 national and global collaborations. Her current work
includes broadening cost-effective options for hepatitis elimination in Italy. She has strong
competencies in Health Technology Assessment and management and analysis of real-life big
databases. She is currently serving as an expert for the Italian Ministry of Health for the National
Hepatitis plan implementation and is a member of the steering committee for HCV screening in
Italy. Her policy and advocacy efforts focus on evidence-based guiding health policies to reduce
chronic liver disease burden. She is currently European Association for the Study of the Liver
(EASL) Policy and Public Health Committee Member. Dr. Kondili has been actively involved in
teaching students and fellows.